1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 19
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY RESEARCH 21
2.1.2.1 Breakdown of primary 21
2.1.2.2 Key data from primary sources 22
2.2 MARKET SIZE ESTIMATION METHODOLOGY 22
2.3 MARKET DATA VALIDATION AND TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 29
4.1 TRANSRADIAL ACCESS DEVICES: MARKET OVERVIEW 29
4.2 TRANSRADIAL ACCESS DEVICES MARKET, BY PRODUCT (2017) 30
4.3 TRANSRADIAL ACCESS DEVICES MARKET, BY APPLICATION, 2017 VS. 2022 31
4.4 GEOGRAPHICAL SNAPSHOT OF THE TRANSRADIAL ACCESS DEVICES MARKET 31

5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Increasing preference for interventional procedures using radial artery access 33
5.2.1.2 Growing prevalence of lifestyle diseases 33
5.2.1.3 Rising prevalence of obesity 33
5.2.1.4 Increasing number of chemotherapy procedures 34
5.2.1.5 Growing use of radial access devices in pediatric patients 34
5.2.2 RESTRAINTS 34
5.2.2.1 High costs involved in the placement and maintenance of vascular access devices 34
5.2.2.2 Product recalls and failures 35
5.2.3 OPPORTUNITIES 35
5.2.3.1 Technological advancements 35
5.2.3.2 Emerging markets 35
5.2.4 CHALLENGES 36
5.2.4.1 Dearth of highly skilled professionals 36
5.2.4.2 Risks associated with radial access devices 36

6 TRANSRADIAL ACCESS DEVICES MARKET, BY PRODUCT 37
6.1 INTRODUCTION 38
6.2 CATHETERS 39
6.3 GUIDEWIRES 41
6.4 SHEATHS AND SHEATH INTRODUCERS 42
6.5 ACCESSORIES 43

7 TRANSRADIAL ACCESS DEVICES MARKET, BY APPLICATION 44
7.1 INTRODUCTION 45
7.2 DRUG ADMINISTRATION 46
7.3 FLUID AND NUTRITION ADMINISTRATION 48
7.4 BLOOD TRANSFUSION 49
7.5 DIAGNOSTICS AND TESTING 50

8 TRANSRADIAL ACCESS DEVICES MARKET, BY END USER 51
8.1 INTRODUCTION 52
8.2 HOSPITALS 54
8.3 CLINICS AND AMBULATORY CARE CENTERS 55
8.4 OTHER END USERS 56

9 TRANSRADIAL ACCESS DEVICES MARKET, BY REGION 57
9.1 INTRODUCTION 58
9.2 NORTH AMERICA 60
9.2.1 US 64
9.2.1.1 Increasing incidence of cancer 64
9.2.1.2 Rising burden of CVDs 64
9.2.1.3 Increasing number of conferences, symposia, and workshops 64
9.2.2 CANADA 66
9.2.2.1 Increasing incidence of CVDs 66
9.2.2.2 Increase in cancer incidence 66
?
9.3 EUROPE 68
9.3.1 INCREASING FOCUS OF MARKET PLAYERS IN EUROPE 68
9.3.2 RISING GERIATRIC POPULATION 68
9.3.3 INCREASING PREVALENCE OF END-STAGE RENAL DISEASE (ESRD) 69
9.3.4 GROWING PREVALENCE OF CANCER IN GERMANY, FRANCE, AND ITALY 69
9.3.5 UK 73
9.3.5.1 Rising prevalence of CVDs with growth in the obese population 73
9.3.5.2 Growing prevalence of cancer in the UK 74
9.3.6 GERMANY 75
9.3.6.1 Increase in the prevalence of target diseases coupled with strengthening of the healthcare infrastructure to propel market growth 75
9.3.6.2 Increasing number of research studies on vascular access devices in Germany 76
9.3.7 FRANCE 78
9.3.7.1 Growth in the geriatric population 78
9.3.8 ROE 79
9.3.8.1 Improving healthcare infrastructure in Russia 79
9.3.8.2 Increasing incidence of cancer in the RoE 79
9.3.8.3 Growth in the healthcare sector & rising medical tourism in Turkey 79
9.4 ASIA PACIFIC 82
9.4.1 JAPAN 85
9.4.1.1 Increasing prevalence of chronic kidney disease in Japan 85
9.4.1.2 Rapid growth in the geriatric population 86
9.4.2 CHINA 87
9.4.2.1 Favorable government initiatives 87
9.4.2.2 Increasing focus of market players on China 87
9.4.3 INDIA 89
9.4.3.1 Increasing incidence of cancer 89
9.4.3.2 High burden of CVDs in India 89
9.4.4 REST OF APAC 91
9.4.4.1 High diabetes prevalence and rising incidence of CVDs in Pacific Countries 91
9.5 REST OF THE WORLD 93
9.5.1 LATIN AMERICA 95
9.5.1.1 High prevalence of obesity in Latin America 95
9.5.2 MIDDLE EAST & AFRICA 97
9.5.2.1 Increasing geriatric population & rise in age-related disorders in the Middle East 97
9.5.2.2 Strengthening of the healthcare infrastructure in the Middle East 97
9.5.2.3 Rising prevalence of cancer in Africa 97
?

10 COMPETITIVE LANDSCAPE 99
10.1 INTRODUCTION 99
10.2 COMPARATIVE ASSESSMENT OF KEY PLAYERS IN THE TRANSRADIAL ACCESS DEVICES MARKET 100
10.3 MARKET SHARE ANALYSIS 101
10.3.1 INTRODUCTION 101
10.3.2 BECTON, DICKINSON AND COMPANY 101
10.3.3 TERUMO CORPORATION 102
10.4 COMPETITIVE SITUATION AND TRENDS 102
10.4.1 PRODUCT LAUNCHES AND APPROVALS 103
10.4.2 ACQUISITIONS 104
10.4.3 EXPANSIONS 105
10.4.4 AGREEMENTS AND COLLABORATIONS 106

11 COMPANY PROFILES 107
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 BECTON, DICKINSON AND COMPANY 107
11.2 TERUMO CORPORATION 110
11.3 TELEFLEX INCORPORATED 113
11.4 SMITHS MEDICAL 116
11.5 MEDTRONIC 119
11.6 EDWARD LIFESCIENCES CORPORATION 122
11.7 MERIT MEDICAL SYSTEMS 124
11.8 BOSTON SCIENTIFIC CORPORATION 126
11.9 NIPRO MEDICAL CORPORATION 129
11.10 ANGIODYNAMICS, INC. 131
11.11 AMECO MEDICAL 133
11.12 OSCOR INC. 134

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12 APPENDIX 135
12.1 DISCUSSION GUIDE 135
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 137
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 139
12.4 AVAILABLE CUSTOMIZATIONS 140
12.5 RELATED REPORTS 141
12.6 AUTHOR DETAILS 142